Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug

Biochemical Pharmacology

Volumn 71, Issue 8, 2006, Pages 1136-1145

  Alderden, R A ^a   Mellor, H R ^b   Modok, S ^b   Hambley, T W ^a   Callaghan, R ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anthraquinone; Cancer; Chemotherapy; Cytotoxicity; Lysosomes; Platinum

Indexed keywords

ANTHRAQUINONE DERIVATIVE; CELL NUCLEUS DNA; CISPLATIN; DOXORUBICIN; PLATINUM AMMINE CYCLOHEXYLAMINE DICHLORIDE; PLATINUM COMPLEX;

ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYDROPHOBICITY; LYSOSOME; PRIORITY JOURNAL;

ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, CONFOCAL; MOLECULAR STRUCTURE; PLATINUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33644827123     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.12.039     Document Type: Article

References (42)

1. R.T. Skeel Antineoplastic drugs and biologic response modifiers: classification, use and toxicity of clinically useful agents R.T. Skeel Handbook of cancer chemotherapy 1999 Lippincott Williams and Wilkins 63 143
2. P.A. Andrews, and S.B. Howell Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance Cancer Cells 2 2 1990 35 43
3. K.R. Harrap Initiatives with platinum- and quinazoline-based antitumor molecules - Fourteenth Bruce F. Cain Memorial Award Lecture Cancer Res 55 13 1995 2761 2768
4. H. Niedner, R. Christen, X. Lin, A. Kondo, and S.B. Howell Identification of genes that mediate sensitivity to cisplatin Mol Pharmacol 60 6 2001 1153 1160
5. M.D. Hall, T.W. Failes, D.E. Hibbs, and T.W. Hambley Structural investigations of palladium(II) and platinum(II) complexes of salicylhydroxamic acid Inorg Chem 41 5 2002 1223 1228
6. L.R. Kelland, S.Y. Sharp, C.F. O'Neill, F.I. Raynaud, P.J. Beale, and I.R. Judson Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance J Inorg Biochem 77 1-2 1999 111 115
7. E. Cvitkovic Ongoing and unsaid on oxaliplatin: the hope Br J Cancer 77 Suppl. 4 1998 8 11
8. M.D. Temple, W.D. McFadyen, R.J. Holmes, W.A. Denny, and V. Murray Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA Biochemistry 39 18 2000 5593 5599
9. K.F. Gean, R. Ben-Shoshan, A. Ramu, I. Ringel, J. Katzhendler, and D. Gibson Preparation, characterization and the anticancer activity of a novel series of triaminemonochloroplatinum(II) cations linked to anthraquinone intercalators Eur J Med Chem 26 1991 593 598
10. D. Gibson, I. Binyamin, M. Haj, I. Ringel, A. Ramu, and J. Katzhendler Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs Eur J Med Chem 32 1997 823 831
11. D. Gibson, K.F. Gean, R. Ben-Shoshan, A. Ramu, I. Ringel, and J. Katzhendler Preparation, characterization, and anticancer activity of a series of cis-PtCl2 complexes linked to anthraquinone intercalators J Med Chem 34 1 1991 414 420
12. D. Gibson, N. Mansur, and K.F. Gean Preparation, characterization, and antitumor properties of cis-PtCl2 complexes linked to anthraquinones through position number 2 J Inorg Biochem 58 2 1995 79 88
13. S. Kitov, R. Ben-Shoshan, I. Ringel, D. Gibson, and J. Katzhendler The effect of cis-platin analogues derived from aminoalkylaminoanthraquinones on DNA cleavage: an electron microscopy study Eur J Med Chem 23 1988 381 383
14. C.C. Cheng, G. Zbinden, and R.K. Zee-Cheng Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics J Pharm Sci 68 3 1979 393 396
15. K.C. Murdock, R.G. Child, P.F. Fabio, R.B. Angier, R.E. Wallace, and F.E. Durr Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-anthracene-9,10-diones J Med Chem 22 9 1979 1024 1030
16. W.A. Denny, and L.P. Wakelin Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity Anticancer Drug Des 5 2 1990 189 200
17. S.A. Islam, S. Neidle, B.M. Gandecha, M. Partridge, L.H. Patterson, and J.R. Brown Comparative computer graphics and solution studies of the DNA interaction of substituted anthraquinones based on doxorubicin and mitoxantrone J Med Chem 28 7 1985 857 864
18. J.W. Lown, A.R. Morgan, S.F. Yen, Y.H. Wang, and W.D. Wilson Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids Biochemistry 24 15 1985 4028 4035
19. P.J. Smith, R. Desnoyers, N. Blunt, Y. Giles, L.H. Patterson, and J.V. Watson Flow cytometric analysis and confocal imaging of anticancer alkylaminoanthraquinones and their N-oxides in intact human cells using 647-nm krypton laser excitation Cytometry 27 1 1997 43 53
20. D. Barasch, O. Zipori, I. Ringel, I. Ginsburg, A. Samuni, and J. Katzhendler Novel anthraquinone derivatives with redox-active functional groups capable of producing free radicals by metabolism: are free radicals essential for cytotoxicity? Eur J Med Chem 34 7-8 1999 597 615
21. L. Cai, K. Lim, S. Ren, R.S. Cadena, and W.T. Beck Synthesis and in vitro antitumor activity of oligonucleotide-tethered and related platinum complexes J Med Chem 44 18 2001 2959 2965
22. A. De Lean, P.J. Munson, and D. Rodbard Simultaneous analysis of families of sigmoidal curves: applications to bioassay, radioligand assay, and physiological dose-response curves Am J Physiol 235 1978 E97 E102
23. J.A. Platts, D.E. Hibbs, T.W. Hambley, and M.D. Hall Calculation of the hydrophobicity of platinum drugs J Med Chem 44 3 2001 472 474
24. M.D. Hall, C. Martin, D.J.P. Ferguson, R.M. Phillips, T.W. Hambley, and R. Callaghan Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models Biochem Pharmacol 67 2004 17 30
25. B.A. Jansen, P. Wielaard, G.V. Kalayda, M. Ferrari, C. Molenaar, and H.J. Tanke Dinuclear platinum complexes with N,N′-bis(aminoalkyl)-1,4- diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells J Biol Inorg Chem 9 4 2004 403 413
26. D.P. Gately, and S.B. Howell Cellular accumulation of the anticancer agent cisplatin: a review Br J Cancer 67 6 1993 1171 1176
27. S. Ishida, J. Lee, D.J. Thiele, and I. Herskowitz Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals Proc Natl Acad Sci USA 99 22 2002 14298 14302
28. X. Lin, T. Okuda, A. Holzer, and S.B. Howell The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae Mol Pharmacol 62 5 2002 1154 1159
29. E.R. Jamieson, S.J. Lippard, and Structure Recognition, and processing of cisplatin-DNA adducts Chem Rev 99 9 1999 2467 2498
30. C. Molenaar, J.M. Teuben, R.J. Heetebrij, H.J. Tanke, and J. Reedijk New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy J Biol Inorg Chem 5 5 2000 655 665
31. R. Safaei, K. Katano, B.J. Larson, G. Samimi, A.K. Holzer, and W. Naerdemann Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells Clin Cancer Res 11 2 Pt 1 2005 756 767
32. X.J. Liang, D.W. Shen, K.G. Chen, S.M. Wincovitch, S.H. Garfield, and M.M. Gottesman Trafficking and localization of platinum complexes in cisplatin-resistant cell lines monitored by fluorescence-labeled platinum J Cell Physiol 202 3 2005 635 641
33. E.J. Gabbay, D. Grier, R.E. Fingerle, R. Reimer, R. Levy, and S.W. Pearce Interaction specificity of the anthracyclines with deoxyribonucleic acid Biochemistry 15 10 1976 2062 2070
34. H.M. Coley, W.B. Amos, P.R. Twentyman, and P. Workman Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines Br J Cancer 67 6 1993 1316 1323
35. D. Marquardt, and M.S. Center Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells Cancer Res 52 11 1992 3157 3163
36. M.E. Leibbrandt, G.H. Wolfgang, A.L. Metz, A.A. Ozobia, and J.R. Haskins Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells Kidney Int 48 3 1995 761 770
37. A. Stacchiotti, R. Rezzani, L. Rodella, and R.G. Ventura Lysosomal changes in rat spinal ganglia neurons after prolonged treatment with cisplatin Acta Anat (Basel) 153 3 1995 236 242
38. S.K. Aggarwal A histochemical approach to the mechanism of action of cisplatin and its analogues J Histochem Cytochem 41 7 1993 1053 1073
39. C. Bour-Dill, M.P. Gramain, J.L. Merlin, S. Marchal, and F. Guillemin Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis Cytometry 39 1 2000 16 25
40. Y. Gong, M. Duvvuri, and J.P. Krise Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60 J Biol Chem 278 50 2003 50234 50239
41. G.V. Kalayda, B.A. Jansen, C. Molenaar, P. Wielaard, H.J. Tanke, and J. Reedijk Dinuclear platinum complexes with N,N′-bis(aminoalkyl)-1,4- diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance J Biol Inorg Chem 9 4 2004 414 422
42. G.V. Kalayda, B.A. Jansen, P. Wielaard, H.J. Tanke, and J. Reedijk Dinuclear platinum anticancer complexes with fluorescent N,N′- bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles J Biol Inorg Chem 10 3 2005 305 315